Aldevron Partners with Acuitas Therapeutics to Boost mRNA LNP Capabilities
Aldevron, a global manufacturer of DNA, RNA, and proteins, has announced a strategic partnership with Acuitas Therapeutics, a private biotechnology company that specialises in the development of delivery systems for nucleic acid therapeutics based on lipid nanoparticles (LNPs). The collaboration